Orbimed Advisors LLC, a director at Aspen Neuroscience, Inc., purchases $15M of stock
1,000,000 shares at about $15.00 each, bought on the open market on Nov 2.
Orbimed Advisors LLC, a director of Aspen Neuroscience, Inc. (ASPE), bought 1,000,000 shares on Nov 2 at an average price of $15.00, a total of about $15 million, according to a Form 4 filed with the SEC on Nov 4.
It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. After the trade, the filing lists 3,589,132 shares held.
Other Aspen Neuroscience, Inc. insiders have also bought: Four insiders made open-market purchases within 14 days, a pattern known as a cluster buy. The trade was reported within two business days, as Section 16 requires.
Details from the SEC filing:
| Company | Aspen Neuroscience, Inc. (ASPE) |
|---|---|
| Insider | Orbimed Advisors LLC |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 1,000,000 |
| Average price | $15.00 |
| Value | $15,000,000 |
| Trade date | Nov 2, 2026 |
| Filed with the SEC | Nov 4, 2026, 6:43 PM ET |
| Shares held after | 3,589,132 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See more details on this insider purchase
See more large insider purchases · See all the latest insider trades
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
